Floatz logo

Esomeprazole

Metastasis, Neoplasm

Fudan UniversitySmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Metastasis, Neoplasm cohort.

Asset / SponsorPhaseRating
Bpi-28592
Betta Pharmaceuticals Co., Ltd.
Phase 1CC

Same molecule, other indications

Esomeprazole is also rated in:

gastrointestinal stromal tumorDormant
BB
Indicative ·
69 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →
morbid obesityDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →